Aquestive Therapeutics, Inc. — Director's Dealing 2024

Jun 21, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Aquestive Therapeutics, Inc. (AQST)
CIK: 0001398733
Period of Report: 2024-06-20

Reporting Person: BROWN GREGORY B (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-06-20	Stock Option (Right to Purchase)	$2.50	A	38000	Acquired	2034-06-20	Common Stock (38000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	75085	Direct

Footnotes

F1: The shares underlying the options vest as follows: 100% of the underlying shares vest June 20, 2025, subject to Dr. Brown's continuous service with the Issuer from the grant date through the applicable vesting date.